05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
Join Ulmer for a live webinar on January 14 at 2 p.m. (ET) as Partner David W. Leopold discusses wha...
Read More >
Seyfarth Synopsis: One of the unique elements of Cal/OSHA is a requirement that ALL employers have ...
Read More >
On Nov. 21, the Queen Mary University of London School of International Arbitration, in partnership ...
Read More >
A few weeks ago, the Work from Home Regulations were published in the Official Gazette, by Executive...
Read More >
As most states, counties, and municipalities across the country lift restrictions on businesses and ...
Read More >
Recent developments regarding immigration across the globe include changes to temporary and permanen...
Read More >